Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016

Mair, C. et al. (2019) Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016. Diabetologia, 62(8), pp. 1375-1384. (doi: 10.1007/s00125-019-4900-7) (PMID:31104095) (PMCID:PMC6647722)

186948.pdf - Published Version
Available under License Creative Commons Attribution.



Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in those with type 1 diabetes in Scotland between 2004 and 2016, and whether any trends differed by sociodemographic factors. Methods: We analysed records from 30,717 people with type 1 diabetes, registered anytime between 2004 and 2016 in the national diabetes database, which contained repeated measures of HbA1c. An additive mixed regression model was used to estimate calendar time and other effects on HbA1c. Results: Overall, median (IQR) HbA1c decreased from 72 (21) mmol/mol [8.7 (4.1)%] in 2004 to 68 (21) mmol/mol (8.4 [4.1]%) in 2016. However, all of the improvement across the period occurred in the latter 4 years: the regression model showed that the only period of significant change in HbA1c was 2012–2016 where there was a fall of 3 (95% CI 1.82, 3.43) mmol/mol. The largest reductions in HbA1c in this period were seen in children, from 69 (16) mmol/mol (8.5 [3.6]%) to 63 (14) mmol/mol (7.9 [3.4]%), and adolescents, from 75 (25) mmol/mol (9.0 [4.4]%) to 70 (23) mmol/mol (8.6 [4.3]%). Socioeconomic status (according to Scottish Index of Multiple Deprivation) affected the HbA1c values: from the regression model, the 20% of people living in the most-deprived areas had HbA1c levels on average 8.0 (95% CI 7.4, 8.9) mmol/mol higher than those of the 20% of people living in the least-deprived areas. However this difference did not change significantly over time. From the regression model HbA1c was on average 1.7 (95% CI 1.6, 1.8) mmol/mol higher in women than in men. This sex difference did not narrow over time. Conclusions/interpretation: In this high-income country, we identified a modest but important improvement in HbA1c since 2012 that was most marked in children and adolescents. These changes coincided with national initiatives to reduce HbA1c including an expansion of pump therapy. However, in most people, overall glycaemic control remains far from target levels and further improvement is badly needed, particularly in those from more-deprived areas.

Item Type:Articles
Additional Information:We are grateful to Diabetes UK (17/0005627) and the Chief Scientist Office (ETM/47) for funding this work.
Glasgow Author(s) Enlighten ID:Lindsay, Dr Robert and Petrie, Professor John and Mair, Dr Colette and Sattar, Professor Naveed
Authors: Mair, C., Wulaningsih, W., Jeyam, A., McGurnaghan, S., Blackbourn, L., Kennon, B., Leese, G., Lindsay, R., McCrimmon, R. J., McKnight, J., Petrie, J. R., Sattar, N., Wild, S. H., Conway, N., Craigie, I., Robertson, K., Bath, L., McKeigue, P. M., and Colhoun, H. M.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Science and Engineering > School of Mathematics and Statistics > Statistics
College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Diabetologia
ISSN (Online):1432-0428
Published Online:18 May 2019
Copyright Holders:Copyright © 2019 The Authors
First Published:First published in Diabetologia 62(8):1375-1384
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record